| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c17612db7d98bb4baf5d622f5250492 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
1982-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95f7f26d914e34bbab79cf2ffbe67b01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28411600d664ad89164ea175fa9c43d8 |
| publicationDate |
1982-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0066505-A1 |
| titleOfInvention |
Pharmaceutical sustained-release preparation of naphthidrofuryl |
| abstract |
The present invention relates to a pharmaceutical preparation of "Naftidrofuryl". Naftidrofuryl and its pharmaceutically acceptable organic and mineral salts are included in a hydrophobic matrix, consisting of a mixture of a lipid substance and of a polymer insoluble in water. The controlled release preparation can be used in the treatment of peripheral and cerebral circulatory disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4892742-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5407686-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0224146-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0224146-A2 |
| priorityDate |
1981-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |